Pacific Biosciences

PACB

Capitalización de mercado USD 640 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
126	126 Vanguard Personalized Indexing Management Oakland, California	USD 42.3 k	-USD 1.37 k	-942	-4%
127	127 Private Wealth Partners Mill Valley, California	USD 42 k	–	–	–
128	128 Axxcess Wealth Management Carlsbad, California	USD 40.6 k	-USD 6.43 k	-4,425	-15%
129	129 Cresset Asset Management Chicago, Illinois	USD 39.5 k	–	–	–
130	130 Ameritas Investment Partners Lincoln, Nebraska	USD 38.5 k	–	–	–
131	131 SVB Capital Management Menlo Park, California	USD 34.6 k	–	–	–
132	132 Principal Financial Group Des Moines, Iowa	USD 34.6 k	+USD 12.5 k	+8,583	+72%
133	133 Brighton Jones LLC Seattle, Washington	USD 34.4 k	+USD 9.43 k	+6,485	+46%
134	134 Neuberger Berman Group New York	USD 34 k	-USD 15.5 k	-10,690	-35%
135	135 Prime Capital Investment Advisors Overland Park, Kansas	USD 33.5 k	-USD 518	-356	-2%
136	136 Bay Colony Advisors Concord, Massachusetts	USD 31.9 k	-USD 4.36 k	-3,000	-14%
137	137 IFP Advisors Tampa, Florida	USD 31.3 k	-USD 23.4 k	-16,097	-46%
138	138 Insigneo Advisory Services Miami, Florida	USD 31.2 k	–	–	–
139	139 Bronte Capital Management Bondi Junction, Australia	USD 30 k	+USD 26 k	+17,881	Nuevas
140	140 Arax Advisory Partners Denver, Colorado	USD 29.9 k	+USD 22.7 k	+15,642	+733%
141	141 Corient Private Wealth Miami, Florida	USD 29.7 k	+USD 1.17 k	+802	+5%
142	142 Private Advisor Group Morristown, New Jersey	USD 29 k	-USD 10.9 k	-7,500	-30%
143	143 ExodusPoint Capital Management New York	USD 28.6 k	+USD 24.7 k	+17,004	Nuevas
144	144 CIBC Bancorp USA Chicago, Illinois	USD 27.2 k	+USD 2.44 k	+1,679	+12%
145	145 Quantinno Capital Management New York	USD 25.8 k	+USD 1.04 k	+718	+5%
146	146 Abel Hall LLC Baton Rouge, Louisiana	USD 25.1 k	-USD 11.2 k	-7,736	-34%
147	147 Ballentine Partners Waltham, Massachusetts	USD 24.2 k	-USD 3.31 k	-2,277	-14%
148	148 Farallon Capital Management San Francisco, California	USD 23.9 k	-USD 176 k	-120,800	-89%
149	149 Mirae Asset Global Investments Seoul, South Korea	USD 23.3 k	-USD 2.71 k	-1,861	-12%
150	150 Tower Research Capital (TRC) New York	USD 23.2 k	-USD 53.4 k	-36,733	-73%

Pacific Biosciences PACB Capitalización de mercado USD 640 M

Pacific Biosciences

PACB

Capitalización de mercado USD 640 M